Health
New ‘SINT1A‘ study explores potential of a probiotic to prevent type 1 diabetes in children – News-Medical.Net
Type 1 diabetes is the most common metabolic disease in children and adolescents worldwide. It can be particularly dangerous as often there is no diagnosis until…
Type 1 diabetes is the most common metabolic disease in children and adolescents worldwide. It can be particularly dangerous as often there is no diagnosis until severe and sometimes life-threatening symptoms have already developed. The new ‘SINT1A‘ study explores the potential of a specific probiotic to strengthen the immune system early-on in children with increased genetic risk of type 1 diabetes, and thus prevent its development.
SINT1A is led by Helmholtz Zentrum Muenchen, and part of the…
-
Business16 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General24 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business18 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
General16 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips